Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
14.55
-0.12 (-0.82%)
Dec 4, 2025, 3:10 PM EST - Market open
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $1.01 billion as of December 4, 2025. Its market cap has increased by 68.80% in one year.
Market Cap
1.01B
Enterprise Value
1.47B
1-Year Change
68.80%
Ranking
Category
Stock Price
$14.55
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $1.01B, an increase of 92.25%. That is a compound annual growth rate of 11.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 1.02B | 84.02% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | 935.68M | 22.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |